The size of the global wound care management devices market is estimated to be growing at a CAGR of 3.8% during the forecast period. The market size is predicted to value USD 25.18 billion by 2026 from USD 20.89 billion in 2021.
Injuries and wounds are common conditions that impact billions of individuals across the world. The products are very resistant to environmental inhibitors and particles, and a nurse supplies them under the direction and supervision of a physician for various reasons. To treat chronic wounds, wound care devices are available on the market. Accidents, burns, trauma, and natural disasters can all result in wounds. Chronic and acute wounds are the two forms of wounds that are commonly seen. Obesity, cardiovascular disease, and diabetes are just a few lifestyle diseases that can cause chronic wounds. Surgical or traumatic wounds, on the other hand, are acute wounds. Wound care treatment has used pharmacological drugs such as angiotensin-converting enzyme (ACE) inhibitors, monoclonal antibodies, topical immunosuppressants, and xanthine oxidase inhibitors.
MARKET DRIVERS:
Factors such as increased cases of burns, increasing demand for anti-infective dressings, and rising prevalence of diabetic ulcers and foot ulcers are expected to drive the wound care management devices market. In addition, the National Center for Biotechnology Information (NCBI) said that between 2 and 3% of the population in developed countries are expected to suffer chronic injury in their lifetime. Other factors responsible for the market's growth include technological advancements by significant players and increased awareness of the importance of wound care management.
Diabetes is the leading injury-causing illness, along with other chronic diseases, and in adults over 63, the diabetic population is over 27%. The incidence of chronic wounds, particularly foot ulcers, is increasing among the diabetic population. Besides, according to the 2020 report of the Federal Statistical Office of Germany, there are currently around 83 million inhabitants in Germany. Of these 16.4 million inhabitants, they are over 65 years old, and this number is expected to reach 22.5 million by 2050. As the number of older people is likely to increase in the near future, they are more prone to chronic diseases such as diabetes. This population is expected to experience skin ulcers in the near future diabetic foot, positively impacting the market. Therefore, the number of diabetic patients is anticipated to escalate with the rise in the geriatric population, stimulating the growth of wound care management devices during the prognostic period.
MARKET RESTRAINTS:
However, the high cost of wound care products and strict government regulations for product approval are expected to impact the market's growth during the forecast period negatively.
Impact of COVID-19 on the global wound care management devices market:
The new COVID-19 pandemic is declared as an emergency public health issue by the WHO. The pandemic has negatively impacted advanced wound care dressings and devices. Countries worldwide reallocated the resources such as hospital beds, nurses, and medical devices to manage COVID 19 patients. Healthcare providers have shifted to new models of care for chronic wounds like telehealth platforms and consultations. Healthcare services like specialized wound care clinics and hospitals with wound care departments have been closed with the available number of hospital beds as they are used for COVID 19 patients. As per the statistics published by Tissue Analytics, Inc., an estimated 40% drop in inpatient visits in wound care centers during March and April 2020 compared to 2019.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Covered |
By Type, Production Technologies, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
This research report on the global wound care management devices market segmented and sub-segmented based on type, production technologies, and region.
Wound Care Management Devices Market – By Product:
Based on the product type, the therapy device segment is expected to dominate the global wound care management device market, owing to many product registrations and its advantages over traditional methods of promoting wound healing by hydration. These devices reduce the risk of infection at the wound site, thereby improving wound healing procedures. Further, the wound care management devices market is expected to be driven by pharmaceutical companies willing to invest in affordable wound care technologies due to chronic wounds' current financial burden. This growth is attributed to the changing preference of healthcare professionals for painless wound closure devices and the increased demand for minimally invasive therapies worldwide. Moreover, the increasing use of absorbable synthetic sutures in cosmetic surgeries is expected to drive market growth in the near future. According to the International Society for Aesthetic Plastic Surgery data, approximately 11,061,134 cosmetic surgery procedures were performed worldwide in 2019.
Wound Care Management Devices Market – By Type of Wound:
The burns segment is expected to be the most lucrative market segment based on the type of wound due to the higher frequency of burns. These can come from flames, vapors, or agents such as chemicals, tar, and electricity. The diabetic foot ulcer segment is estimated to increase at a significant CAGR over the prognosis period due to the increasing number of diabetic patients. They're more prone to foot ulcers. According to data published by the American Podiatric Medical Association, in 2020, about 17% of diabetic patients developed foot ulcers, of which about 7% were hospitalized due to other ulcer-related complications and infections. In addition, diabetes is one of the leading causes of non-traumatic lower-limb amputations in the United States, and about 15-25% of them are diabetic patients. Hence, increasing the diabetic population in the world is expected to boost the wound care management devices market for the diabetic foot ulcer segment.
Wound Care Management Devices Market – By End User:
Based on the end-user, the home care settings segment is expected to experience the fastest growth rate due to the growing awareness of wound care management devices and their use.
Wound Care Management Devices Market – By Region:
Geographically, North America presently dominates the global wound care management devices market and is estimated to sustain its stronghold for a few more years.
North America is expected to dominate the global market in 2020, owing to the increasing prevalence of foot ulcers. The American Podiatric Medical Association (APMA) said in 2020 that diabetes is the leading cause of non-traumatic lower-limb amputation in the United States. About 15 to 25% of patients who suffer from foot ulcers require amputation.
The European market is expected to accumulate a significant market share due to the increase in accident cases. According to an article published by Deutsche Welle, around 387,500 people in Germany were injured due to traffic accidents in 2019, increasing 5,906 cases since 2017.
Asia Pacific region is anticipated to increase its market share due to the increase in technological advancements. In addition, the market for wound care management devices in the Asia-Pacific area is expected to grow at the fastest CAGR due to the increasing number of surgeries causing injury and increasing healthcare spending.
The LAMEA market is expected to grow slowly, owing to the development of healthcare infrastructure in Latin America and the Middle East region.
KEY MARKET PARTICIPANTS:
Companies playing a leading role in the global wound care management devices market profiled in this report are Coloplast A/S (Denmark.), Baxter International Inc. (U.S.), Hollister Inc. (U.S.), Mölnlycke Health Care (Sweden), 3M Company (U.S.), Covidien PLC (Ireland), Ethicon Inc. (U.S.), Derma Sciences Inc. (U.S.), Convatec Healthcare B.S.A.R.L (U.S.), Acelity L.P/ (U.S.) and Smith & Nephew (U.K.).
Top companies operating in this market have adopted strategies such as acquisitions and new product launches to stabilize and maximize their market share.
RECENT MARKET HAPPENINGS:
Related Reports
